Locations
San Diego, CA, USA · North America
industry
Biotechnology · Community and Lifestyle · DeepTech · Health
Size
51-200 employees
Stage
Series A
founded in
2018
Gallant Pet is a pioneering company in veterinary regenerative medicine, specializing in stem cell therapies to treat pets with inflammatory and immune-mediated diseases. By harnessing the power of mesenchymal stem cells, Gallant aims to address the root causes of diseases rather than just the symptoms, offering innovative treatments that can significantly improve the quality of life for pets. The company is actively involved in clinical trials and has a strong commitment to research and development, positioning itself as a leader in the veterinary medicine market. Founded by Aaron Hirschhorn, Gallant has attracted investment from notable venture capital firms and continues to expand its impact in animal health.
Something looks off?